SAM #SBSS75N93026R00015

Preclinical Services for HIV Therapeutics Research – Sources Sought

This opportunity is issued by the National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID), seeking small business sources for preclinical services supporting HIV therapeutics research. - Government Buyer: - Department of Health and Human Services (DHHS) - National Institutes of Health (NIH) - National Institute of Allergy and Infectious Diseases (NIAID) - Office of Acquisition and Logistics Management - Services Requested: - In vitro testing and high throughput screening of antiviral therapeutic agents (6 task orders) - Synthesis of therapeutic agents for HIV, TB, hepatitis B and C (2 task orders) - Efficacy models for HIV, HBV, HCV (2 task orders) - Efficacy models for Mycobacterium tuberculosis and co-infections (2 task orders) - Formulation development and manufacture of clinical dosage forms (1 task order) - Preclinical pharmacology and toxicology studies (3 task orders) - Diagnostic development services for in vitro diagnostic technologies (2 task orders) - Unique/Notable Requirements: - Services must support research materials, drug screening, synthesis, animal models, and regulatory compliance for HIV and related infectious diseases - Animal models exclude primates and require BSL-3 facilities for Mycobacterium studies - Formulation and manufacturing must comply with cGMP guidelines - Preclinical studies must support regulatory submissions (GLP and non-GLP) - Diagnostic development excludes clinical evaluations and regulatory submissions - No specific OEMs, vendors, products, or part numbers are mentioned; focus is on specialized preclinical research services. - The anticipated contract period is 7 years, with multiple IDIQ contracts and task orders, primarily cost-reimbursement.

Description

The Small Business Sources Sought Notice is attached.   

View original listing